(d) the Respondent shall also sign any written release/consent forms to
authorize MPRP to exchange with (i.c., disclose to and receive from) outside
entities (including all of the Respondent’s current therapists and treatment
providers) verbal and written information concerning the Respondent and to
ensure that MPRP is authorized to receive the medical records of the
Respondent, including, but not limited to, mental health and drug or alcohol
evaluation and treatment records. The Respondent shall not withdraw his
release/consent;

(e) the Respondent’s failure to comply with any of the above terms or
conditions including terms or conditions of the Participant Rehabilitation
Agreement(s) or Participant Rehabilitation Plan(s) constitutes a violation of
this Consent Order;

(2) the Respondent is prohibited from prescribing and dispensing controlled
dangerous substance medications until after the Respondent has
successfully completed the courses described in probation condition (3) and
has a supervisor approved by the Panel as described in probation condition
(4). The prohibition on prescribing and dispensing may be administratively
terminated through an Order of the Panel upon the Respondent’s proof of
successful completion of the courses and after the Panel has approved the
Respondent’s proposed supervisor. The following conditions also apply:

(a) the Respondent shall not delegate to any physician assistant the
prescribing of controlled dangerous substances;

(b) the Respondent is prohibited from certifying patients for the medical
use of cannabis;

(c) the Panel may issue administrative subpoenas to the Maryland
Prescription Drug Monitoring Program on a quarterly basis for the
Respondent’s Controlled Dangerous Substances (“CDS”)
prescriptions. The administrative subpoenas will request the
Respondent’s CDS prescriptions from the beginning of each quarter;

(d) the Respondent agrees that the CDS Registration issued by the Office
of Controlled Substances Administration will be restricted to the same
categories of CDS medications as limited by this Consent Order, and

(3) Within SIX (6) MONTHS, the Respondent is required to take and
successfully complete two courses, (1) a course in prescribing of controlled.
dangerous substances that deals, at least in part, with prescribing of stimulants

17
